Optimal monitoring of bypass therapy in hemophilia A patients with inhibitors by the use of clot waveform analysis.

Abstract

BACKGROUND Assays to determine the optimal hemostatic effects of bypass therapy in hemophilia A (HA) patients with inhibitors are difficult to compare. Clot waveform analysis (CWA), based on the continuous monitoring of routine coagulation parameters (prothrombin time/activated partial thromboplastin time), offers a useful method for assessing global… (More)
DOI: 10.1111/jth.12488

Topics

  • Presentations referencing similar topics